News

ChemGenex Pharmaceuticals (ChemGenex) and Hospira have entered into an exclusive agreement to license, develop and commercialise the former’s omacetaxine mepesuccinate, a targeted cytotoxic pharmaceutical product, in Europe, the

PharmaVigilant has introduced I-Builder 2.0, a study-building solution that is expected to ease the study build process and technology transfer for sponsors. I-Builder can support multiple users for

FirstCare Health Plans has selected all-in-one IP communications software suite from Interactive Intelligence. The software suite, customer interaction center (CIC), has given FirstCare the ability to support multichannel

ImmunoGen has presented positive clinical data on trastuzumab-DM1 (T-DM1), at the 32nd Annual San Antonio Breast Cancer Symposium. T-DM1 comprises ImmunoGen’s DM1 cancer-cell killing agent linked to the

bioTheranostics has reported findings from three studies using the company’s breast cancer molecular test. Data from the studies were presented at the CTRC-AACR San Antonio Breast Cancer Symposium

Roche’s Stage, a Phase III trial evaluating Ocrelizumab as a treatment for seropositive rheumatoid arthritis (RA) patients with a previous inadequate response to methotrexate (MTX), met its primary

Amcor has appointed Ralf Wunderlich, former MD of Linpac Packaging as the new head of its Asia-Pacific flexibles business. The company will there after concentrate on acquisition of

BP Petronas Acetyls Sdn Bhd (BPPA) has announced its plans to increase its acetic acid production from Paka plant to 600,000 tonnes annually from next the year, reported

India-based IOL chemicals and Pharmaceuticals (IOLCP) has initiated the manufacturing operations at its new plant of isobutyl benzene(IBB) having annual capacity of 6600 MT to ensure ready availability